Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
2.920
-0.170 (-5.50%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Incannex Healthcare Employees
Incannex Healthcare had 12 employees as of June 30, 2025. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,034,500
Market Cap
34.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 12 | 3 | 33.33% |
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 269 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Aytu BioPharma | 83 |
| BioXcel Therapeutics | 29 |
| SCYNEXIS | 18 |
| Talphera | 12 |
IXHL News
- 23 days ago - Incannex Healthcare Quarterly report: Q3 2026 - Filings
- 24 days ago - Incannex commences DReaMzz clinical study of IHL-42X in OSA - TheFly
- 24 days ago - Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea - GlobeNewsWire
- 26 days ago - Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development - GlobeNewsWire
- 4 weeks ago - Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough - GlobeNewsWire
- 6 weeks ago - Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness - GlobeNewsWire
- 2 months ago - Incannex reactivates share repurchase program - TheFly
- 2 months ago - Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position - GlobeNewsWire